more

Owens & Minor (OMI)

(Real Time Quote from BATS)

$15.78 USD

-0.35 (-2.17%)

Updated Aug 27, 2024 01:12 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank	Definition	Annualized Return
1	Strong Buy	23.68%
2	Buy	17.55%
3	Hold	9.21%
4	Sell	4.93%
5	Strong Sell	2.36%
S&P	500	10.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5 3

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score	A
Growth Score	A
Momentum Score	A
VGM Score	A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth C Momentum A VGM

Industry Rank:

Top 39% (98 out of 251)

Industry: Medical - Products

View All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Strength Seen in Owens & Minor (OMI): Can Its 36.2% Jump Turn into More Strength?

by Zacks Equity Research Published on May 27,2021

Owens & Minor (OMI) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.

OMINegative Net Change

Here's Why You Should Hold on to Exact Sciences (EXAS) Stock

by Zacks Equity Research Published on May 26,2021

Investors are optimistic about Exact Sciences (EXAS) on solid first-quarter performance and strategic partnerships.

medical

Abbott (ABT) Organic Growth Strong, Pediatric Nutrition Down

by Zacks Equity Research Published on May 26,2021

Within Medical Device, Abbott (ABT) is facing challenging conditions in terms of procedure volume.

medical

Here's Why You Should Hold On to Zimmer Biomet (ZBH) Stock Now

by Zacks Equity Research Published on May 25,2021

Investors are optimistic about Zimmer Biomet (ZBH) on solid first-quarter results and a gradually stabilizing global musculoskeletal market.

medical

6 Valuable Price-to-Book Stocks to Boost Your Portfolio

by Kinjel Shah Published on May 25,2021

P/B ratio is emerging as a convenient tool to identify low-priced stocks that have high-growth prospects.

Top Ranked Growth Stocks to Buy for May 21st

by Zacks Equity Research Published on May 21,2021

COLM, OMI, AN, and HRI made it to the Zacks Rank #1 (Strong Buy) growth stocks list on May 21, 2021

Add These 5 Low P/CF Stocks to Create a Value-Based Portfolio

by Sumit Singh Published on May 20,2021

Value investing is essentially about selecting stocks that are usually cheap but fundamentally sound. Boise Cascade Company (BCC), Vishay Intertechnology (VSH), Owens & Minor (OMI), Sanmina Corporation (SANM) and Invesco (IVZ) boast low P/CF ratio.

LabCorp's (LH) New Bioanalytical Lab to Boost APAC Operation

by Zacks Equity Research Published on May 20,2021

The new laboratory by LabCorp (LH) is set to enable faster data turnaround for early phase trials in Asia-Pacific markets.

medical

Thermo Fisher (TMO) to Boost Cell Therapies With UCSF Deal

by Zacks Equity Research Published on May 20,2021

Thermo Fisher's (TMO) collaboration with UCSF will enable end-to-end solution to accelerate cell therapy development and manufacturing with new facility.

medical

TeleFlex (TFX) Urolift Grows, Organic Sales Hit by Pandemic

by Zacks Equity Research Published on May 18,2021

On the strength of a successful 2020 campaign, Teleflex (TFX) doubles the awareness for UroLift in the targeted population of men with BPH.

medical

LabCorp's (LH) Pixel Kit Gets EUA for Younger Population

by Zacks Equity Research Published on May 18,2021

LabCorp (LH) becomes the first major commercial laboratory to offer a COVID-19 PCR Test Home Collection Kit for children and adolescents.

medical

Abbott (ABT) Receives CE Mark for Latest Navitor TAVI System

by Zacks Equity Research Published on May 18,2021

Abbott's (ABT) latest-generation Navitor TAVI system features improvements to reduce or eliminate a backflow of blood around valve implants.

medical

Here's Why You Should Buy Henry Schein (HSIC) Stock Now

by Zacks Equity Research Published on May 18,2021

Investors are optimistic about Henry Schein (HSIC) on solid first-quarter performance and strategic deals.

medical